


Searching News Database: Chronic Idiopathic Constipation
HSMN NewsFeed - 5 Mar 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
HSMN NewsFeed - 8 Jul 2015
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
HSMN NewsFeed - 18 Oct 2012
Vibrant Announces Positive Results of Pilot Trial Using Vibrating Capsule for Chronic Constipated Patients
Vibrant Announces Positive Results of Pilot Trial Using Vibrating Capsule for Chronic Constipated Patients
HSMN NewsFeed - 2 May 2012
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
HSMN NewsFeed - 22 Feb 2008
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
HSMN NewsFeed - 30 Mar 2007
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
HSMN NewsFeed - 3 Jan 2007
Sucampo Appoints Veteran Financial Executive Ronald W. Kaiser as Chief Financial Officer
Sucampo Appoints Veteran Financial Executive Ronald W. Kaiser as Chief Financial Officer
HSMN NewsFeed - 23 Oct 2006
New Data for Zelnorm(R) Demonstrate Relief of Multiple Symptoms of Dysmotility-Type Dyspepsia
New Data for Zelnorm(R) Demonstrate Relief of Multiple Symptoms of Dysmotility-Type Dyspepsia
Additional items found! 10
Members Archive contains
10 additional stories matching:
Chronic Idiopathic Constipation
(Password required)
Chronic Idiopathic Constipation
(Password required)
